Related Experiment Video
Updated: Apr 11, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Continuous glucose monitoring and pumps
1Manager, Diabetes Services, Baker IDI Heart and Diabetes Institute, Melbourne, VIC.
Background:
While multiple daily insulin injections remains the state-of-the-art treatment for type 1 diabetes, continuous subcutaneous insulin infusion (CSII) has become increasingly popular in recent years. Up to 40% of people with type 1 diabetes in younger age groups are now using CSII. Very recently, continuous glucose monitoring (CGM) has been developed. This technology now has proven benefits in HbA1c and hypoglycaemia reduction.
Objective:
This article reviews the use of insulin pumps and CGM in the treatment of diabetes mellitus.
Discussion:
The combination of CSII and CGM has added benefits and we are heading rapidly towards a closed-loop system, or artificial pancreas. Patients likely to benefit from these technologies include those with frequent severe hypoglycaemia or poor glycaemic control despite good compliance and education. Given the rapid rise in the development of these technologies, it is important that primary care clinicians are aware and able to discuss these technologies with potential candidates.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Diabetes Mellitus: Type 2 and Gestational
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

